Assessing HIV Vulnerability and the Use of Oral Pre-Exposure Prophylaxis (PrEP) in Injecting Drug Users in Nairobi: A Cross-Sectional Analysis - Scorecard - MDSpire
Advertisement
Assessing HIV Vulnerability and the Use of Oral Pre-Exposure Prophylaxis (PrEP) in Injecting Drug Users in Nairobi: A Cross-Sectional Analysis
Clinical Scorecard: Assessing HIV Vulnerability and the Use of Oral Pre-Exposure Prophylaxis (PrEP) in Injecting Drug Users in Nairobi: A Cross-Sectional Analysis
At a Glance
Category
Detail
Condition
HIV infection risk among people who inject drugs (PWID)
Key Mechanisms
HIV transmission via sexual contact and injection drug use; PrEP reduces risk by 99% for sexual transmission and 74% for injection-related transmission
Target Population
HIV-negative people who inject drugs (PWID) in Nairobi, Kenya
Care Setting
Drop-in centers (DICs) operated by Support for Addictions Prevention and Treatment in Africa (SAPTA)
Key Highlights
PWID globally have 22 to 24 times higher risk of HIV infection compared to the general population.
PrEP is 74%-84% effective in preventing HIV acquisition among PWID when taken regularly.
Barriers to PrEP uptake among PWID include lack of awareness, provider hesitancy, stigma, socioeconomic factors, and limited healthcare access.
Guideline-Based Recommendations
Diagnosis
Identify HIV-negative PWID at substantial risk through targeted outreach and screening in community-based settings.
Management
Offer oral PrEP to HIV-negative PWID as part of comprehensive HIV prevention strategies.
Address misconceptions and increase awareness about PrEP among PWID through tailored education.
Engage healthcare providers to reduce hesitancy in prescribing PrEP to PWID.
Monitoring & Follow-up
Monitor adherence to PrEP among PWID to ensure effectiveness.
Provide ongoing support to address socioeconomic and behavioral barriers to PrEP adherence.
Risks
Potential challenges include stigma, side effect concerns, homelessness, cost, and limited access to knowledgeable healthcare providers.
Patient & Prescribing Data
HIV-negative PWID in Nairobi attending SAPTA drop-in centers
Despite national recommendations since 2017, PrEP uptake remains low due to lack of awareness and provider reluctance; targeted interventions are needed to improve knowledge, access, and adherence.
Clinical Best Practices
Implement peer educator-led outreach to improve PrEP awareness among PWID.
Integrate PrEP services within existing addiction treatment and harm reduction programs.
Address structural barriers such as stigma and socioeconomic challenges to facilitate PrEP uptake.
Train healthcare providers to proactively discuss and prescribe PrEP to PWID.
A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness
